Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dermatomyositis.

G Mintz1

  • 1Postgraduate Division, School of Medicine, Universidad Nacional Autonoma de Mexico, Mexico City.

Rheumatic Diseases Clinics of North America
|May 1, 1989
PubMed
Summary
This summary is machine-generated.

Pregnancy in dermatomyositis/polymyositis (DM/PM) is high-risk. While maternal outcomes are good, fetal prognosis varies significantly based on disease onset and treatment, necessitating careful management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Study comparing the double kissing (DK) crush with classical crush for the treatment of coronary bifurcation lesions: the DKCRUSH-1 Bifurcation Study with drug-eluting stents.

European journal of clinical investigation·2008
Same author

Carotid artery stenting in patients with high-risk anatomy for carotid endarterectomy.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists·2001
Same author

Patience in the pursuit of perfection.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2000
Same author

Mechanical properties and imaging characteristics of remanufactured intravascular ultrasound catheters.

International journal of cardiac imaging·2000
Same author

Promises, promises: the covered stent.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2000
Same author

Percutaneous hemostatic closure systems: is the cost worth the price?

Catheterization and cardiovascular diagnosis·1996
Same journal

Bridging the Divide in Global Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Foreword.

Rheumatic diseases clinics of North America·2026
Same journal

Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases.

Rheumatic diseases clinics of North America·2026
Same journal

Artificial Intelligence and Social Determinants of Health.

Rheumatic diseases clinics of North America·2026
Same journal

Updates in Ultrasound in Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Health Systems Strengthening to Promote Access to Care for Rheumatic and Musculoskeletal Diseases Globally.

Rheumatic diseases clinics of North America·2026
See all related articles

Area of Science:

  • Rheumatology
  • Obstetrics
  • Maternal-Fetal Medicine

Background:

  • Pregnancy in patients with dermatomyositis/polymyositis (DM/PM) is uncommon, often due to the disease's late onset.
  • Existing literature on pregnancy outcomes in DM/PM is limited, particularly concerning disease activity during gestation.

Purpose of the Study:

  • To evaluate the impact of pregnancy on DM/PM activity and assess pregnancy outcomes in women with DM/PM.
  • To identify risk factors associated with adverse fetal outcomes in DM/PM pregnancies.

Main Methods:

  • Retrospective analysis of pregnancy cases in women with DM/PM.
  • Comparison of outcomes based on disease onset (pre-pregnancy vs. during pregnancy) and treatment status (steroid-naïve vs. steroid-treated).

Related Experiment Videos

Main Results:

  • Pregnancy onset of DM/PM is associated with the highest fetal mortality (62%).
  • Pre-existing DM/PM in remission carries a 40% exacerbation risk, but with better fetal prognosis.
  • Active DM/PM under steroid treatment shows lower exacerbation rates (16%) but poorer fetal outcomes (50% at-term, 37.5% fetal loss).
  • No maternal deaths were reported; newborns showed no signs of maternal disease.

Conclusions:

  • Pregnancy in DM/PM is a high-risk condition requiring specialized management.
  • Optimal management includes adequate prednisone therapy, frequent fetal monitoring, and timely intervention.
  • The interaction between DM/PM and pregnancy remains poorly understood.